Search

Your search keyword '"Lawrance, Ian C."' showing total 412 results

Search Constraints

Start Over You searched for: Author "Lawrance, Ian C." Remove constraint Author: "Lawrance, Ian C."
412 results on '"Lawrance, Ian C."'

Search Results

2. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

4. Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

6. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

8. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

9. Crohn's disease management after intestinal resection: a randomised trial

10. An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis

12. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study

13. Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease

19. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

21. Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM

26. An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.

28. An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis

30. Fine-mapping inflammatory bowel disease loci to single-variant resolution

31. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease:Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes

33. Natalizumab induction and maintenance therapy for Crohn's disease

36. Clinical risk stratification accurately predicts development of endoscopic recurrence after Crohnʼs disease surgery: early results from the prospective POCER study

37. Adalimumab prevents post-operative Crohnʼs disease recurrence, and is superior to thiopurines: early results from the POCER study

Catalog

Books, media, physical & digital resources